Newsfeeds - Spark Newswire

2 minute read

Reported Late Monday, Marinus Pharmaceuticals Announces Pricing Of $60M Public Offering Of 10,526,316 Shares Of Its Common Stock At A Price Of $4.75/Share

Today, 11:01 AM

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the pricing of its underwritten public offering of

MRNS

1 minute read

Marinus Pharmaceuticals Q3 EPS $1.89 Up From $(0.53) YoY

By Benzinga Newsdesk

Today, 11:01 AM

Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly earnings of $1.89 per share. This is a 456.6 percent increase over losses of $(0.53) per share from the same period last year.

MRNS

1 minute read

News

Marinus Pharmaceuticals-Sponsored Study: Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related Epilepsy (TrustTSC OLE) Posted to ClinicalTrials.gov Website; Study is Enrolling by invitation

By Charles Gross

Today, 11:01 AM

https://clinicaltrials.gov/ct2/show/NCT05604170

MRNS

2 minute read

Marinus Pharmaceuticals Announces $32.5M Revenue Interest Financing Agreement With Sagard Healthcare Partners

By Benzinga Newsdesk

Today, 11:01 AM

MRNS

1 minute read

BARDA Exercises First Contract Option With Marinus Pharma For Its Epilepsy Candidate

By Vandana Singh

Today, 11:01 AM

Marinus Pharmaceuticals Inc (NASDAQ:MRNS) announced that the Biomedical Advanced Research and Development Authority (BARDA) exercised its first contract option,…

MRNS

1 minute read

Marinus Pharmaceuticals Announces Exercise Of First Contract Option By Biomedical Advanced Research And Development Authority

By Bill Haddad

Today, 11:01 AM

MRNS

1 minute read

Marinus Pharmaceuticals Q2 EPS $(1.06) Misses $(0.68) Estimate, Sales $1.79M Miss $2.31M Estimate

By Benzinga Newsdesk

Today, 11:01 AM

Marinus Pharmaceuticals (NASDAQ:MRNS) reported quarterly losses of $(1.06) per share which missed the analyst consensus estimate of $(0.68) by 55.88 percent. This is a 63.08 percent decrease over losses of $(0.65) per

MRNS

17 minute read

Earnings Scheduled For August 11, 2022

By Benzinga Insights

Today, 11:01 AM

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

AACG